Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorIsler B.
dc.contributor.authorFalconer C.
dc.contributor.authorVatansever C.
dc.contributor.authorÖzer B.
dc.contributor.authorÇınar G.
dc.contributor.authorAslan A.T.
dc.contributor.authorForde B.
dc.date.accessioned2024-02-04T13:30:11Z
dc.date.available2024-02-04T13:30:11Z
dc.date.issued2022
dc.identifier.issn00222615
dc.identifier.urihttps://doi.org/10.1099/jmm.0.001629
dc.identifier.urihttp://hdl.handle.net/11446/4861
dc.description.abstractIntroduction. Aminoglycosides are used for the treatment of carbapenemase-producing Klebsiella pneumoniae (CPK) infections. 16S rRNA methyltransferases (RMTs) confer resistance to all aminoglycosides and are often cocarried with NDM. Hypothesis/Gap Statement. There is a dart of studies looking at the aminoglycoside resistance mechanisms for invasive CPK isolates, particularly in OXA-48 endemic settings. Aim. We aimed to determine the prevalence of RMTs and their association with beta lactamases and MLSTs amongst aminoglycoside-resistant CPK bloodstream isolates in an OXA-48 endemic setting. Methodology. CPK isolates (n=181), collected as part of a multicentre cohort study, were tested for amikacin, gentamicin and tobramycin susceptibility using custom-made sensititre plates (GN2XF, Thermo Fisher Scientific). All isolates were previously subjected to whole-genome sequencing. Carbapenemases, RMTs, MLSTs and plasmid incompatibility groups were detected on the assembled genomes. Results. Of the 181 isolates, 109(60%) were resistant to all three aminoglycosides, and 96 of 109(88%) aminoglycoside-resistant isolates carried an RMT (85 ArmA, 10 RmtC, 4 RmtF1; three isolates cocarried ArmA and RmtC). Main clonal types associated with ArmA were ST2096 (49/85, 58%) and ST14 (24/85, 28%), harbouring mainly OXA-232 and OXA-48 +NDM, respectively. RmtC was cocarried with NDM (5/10) on ST395, and NDM +OXA-48 or NDM +KPC (4/10) on ST14, ST15 and ST16. All RMT producers also carried CTX-M-15, and the majority cocarried SHV-106, TEM-150 and multiple other antibiotic resistance genes. The majority of the isolates harboured a combination of IncFIB, IncH and IncL/M type plasmids. Non-NDM producing isolates remained susceptible to ceftazidime-avibactam. Conclusion. Aminoglycoside resistance amongst CPK bloodstream isolates is extremely common and mainly driven by clonal spread of ArmA carried on ST2096 and ST14, associated with OXA-232 and OXA48 +NDM carriage, respectively. © The Authors.en_US
dc.description.sponsorshipPfizer: 56644459; Queensland Governmenten_US
dc.description.sponsorshipThis work was supported by Pfizer Global Medical Grants (grant number 56644459). Dr Brian Forde’s research is supported by Advance Queensland Industry Research Fellowship from the Queensland Government.en_US
dc.language.isoengen_US
dc.publisherMicrobiology Societyen_US
dc.relation.ispartofJournal of Medical Microbiologyen_US
dc.identifier.doi10.1099/jmm.0.001629
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject16S rRNA methyltransferaseen_US
dc.subjectaminoglycoside resistanceen_US
dc.subjectArmAen_US
dc.subjectbloodstreamen_US
dc.subjectcarbapenem-resistanten_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectNDMen_US
dc.subjectOXA-232en_US
dc.subjectOXA-48en_US
dc.subjectamikacinen_US
dc.subjectaminoglycosideen_US
dc.subjectavibactam plus ceftazidimeen_US
dc.subjectbeta lactamaseen_US
dc.subjectcarbapenemaseen_US
dc.subjectcolistinen_US
dc.subjectgentamicinen_US
dc.subjectmethyltransferaseen_US
dc.subjectRNA 16Sen_US
dc.subjecttigecyclineen_US
dc.subjecttobramycinen_US
dc.subjectaminoglycosideen_US
dc.subjectantiinfective agenten_US
dc.subjectbacterial proteinen_US
dc.subjectmethyltransferaseen_US
dc.subjectRNA 16Sen_US
dc.subjectaminoglycoside resistanceen_US
dc.subjectantibiotic resistanceen_US
dc.subjectantibiotic sensitivityen_US
dc.subjectArticleen_US
dc.subjectbacterium isolateen_US
dc.subjectcohort analysisen_US
dc.subjectcontrolled studyen_US
dc.subjecthumanen_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectmajor clinical studyen_US
dc.subjectnonhumanen_US
dc.subjectobservational studyen_US
dc.subjectphylogenetic treeen_US
dc.subjectplasmiden_US
dc.subjectprevalenceen_US
dc.subjecttrimethoprim resistanceen_US
dc.subjectTurkey (republic)en_US
dc.subjectwhole genome sequencingen_US
dc.subjectcarbapenem-resistant Enterobacteriaceaeen_US
dc.subjectgeneticsen_US
dc.subjectKlebsiella infectionen_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectmicrobial sensitivity testen_US
dc.subjectprevalenceen_US
dc.subjectAminoglycosidesen_US
dc.subjectAnti-Bacterial Agentsen_US
dc.subjectBacterial Proteinsen_US
dc.subjectbeta-Lactamasesen_US
dc.subjectCarbapenem-Resistant Enterobacteriaceaeen_US
dc.subjectCohort Studiesen_US
dc.subjectHumansen_US
dc.subjectKlebsiella Infectionsen_US
dc.subjectKlebsiella pneumoniaeen_US
dc.subjectMethyltransferasesen_US
dc.subjectMicrobial Sensitivity Testsen_US
dc.subjectPrevalenceen_US
dc.subjectRNA, Ribosomal, 16Sen_US
dc.titleHigh prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolatesen_US
dc.typearticleen_US
dc.departmentDBÜen_US
dc.identifier.issue12en_US
dc.identifier.volume71en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempIsler, B., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia, Infection Management Services, Princess Alexandra Hospital, Brisbane, Australia; Falconer, C., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia; Vatansever, C., Infectious Diseases and Clinical Microbiology, School of Medicine, Koç University, Istanbul, Turkey; Özer, B., Infectious Diseases and Clinical Microbiology, School of Medicine, Koç University, Istanbul, Turkey; Çınar, G., Infectious Diseases and Clinical Microbiology, Ankara University, School of Medicine, Ankara, Turkey; Aslan, A.T., Infectious Diseases and Clinical Microbiology, Hacettepe University, School of Medicine, Ankara, Turkey; Forde, B., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia; Harris, P., University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia; Şimşek, F., Infectious Diseases and Clinical Microbiology, University of Health Sciences, Ministry of Health Prof Dr Cemil Taşçıoğlu City Hospital, Istanbul, Turkey; Tülek, N., Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Atilim University, Ankara, Turkey; Demirkaya, H., Infectious Diseases and Clinical Microbiology, Başkent Universien_US
dc.identifier.pmid36748503en_US
dc.identifier.scopus2-s2.0-85147460921en_US
dc.authorscopusid57206274628
dc.authorscopusid57221350758
dc.authorscopusid57214119170
dc.authorscopusid57210635288
dc.authorscopusid57210793543
dc.authorscopusid57208546633
dc.authorscopusid35746149500


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster